There still lacks evidence to support the theory that proton-beam therapy is more effective than traditional therapy when it comes to treating prostate cancer; however, it would be hard to deduce that fact based on the rapidly growing popularity of proton therapy centers.
There still lacks evidence to support the theory that proton-beam therapy is more effective than traditional therapy when it comes to treating prostate cancer; however, it would be hard to deduce that fact based on the rapidly growing popularity of proton therapy centers.
Why would medical organizations want to take on such a costly technology? Because the machines also have the potential to bring in massive amounts of revenue. According to an article by Bloomberg Businessweek, these 500-ton machines — which are stored in “facilities that cost from $100 million to $200 million, and can require a football- field sized building to house” – can bring in as much as $50 million in revenue annually.
The only problem is that there lacks a body of evidence to support the use of proton-beam therapy as opposed to more traditional forms of therapy. According to Amitabh Chandra, a health economist at Harvard University’s John F. Kennedy School of Government, these proton therapy centers are “a metaphor for all the problems we have in American medicine” because of how they complicate the healthcare system. One commenter went as far as to say that this technology has “forced many doctors to become snake oil salesmen in an effort to pay for the equipment that there facility has bought into.”
The growing use of these types of costly technologies begs the question: Do the current pressures being placed on physicians under healthcare reform force them to look for other ways to supplement their practice revenue? More importantly, are these moves improving the quality of care delivered to their patients, or simply improving their bottom line? What are your thoughts?
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More